326 related articles for article (PubMed ID: 28978662)
1. Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes.
Park Y; Lee J; Kwak JY; Noh K; Yim E; Kim HK; Kim YJ; Broxmeyer HE; Kim JA
J Leukoc Biol; 2018 Jan; 103(1):53-66. PubMed ID: 28978662
[TBL] [Abstract][Full Text] [Related]
2. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
[TBL] [Abstract][Full Text] [Related]
3. Protective roles of the fractalkine/CX3CL1-CX3CR1 interactions in alkali-induced corneal neovascularization through enhanced antiangiogenic factor expression.
Lu P; Li L; Kuno K; Wu Y; Baba T; Li YY; Zhang X; Mukaida N
J Immunol; 2008 Mar; 180(6):4283-91. PubMed ID: 18322241
[TBL] [Abstract][Full Text] [Related]
4. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
[TBL] [Abstract][Full Text] [Related]
5. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
6. CX
Lee YS; Kim MH; Yi HS; Kim SY; Kim HH; Kim JH; Yeon JE; Byun KS; Byun JS; Jeong WI
Sci Rep; 2018 Oct; 8(1):15076. PubMed ID: 30305672
[TBL] [Abstract][Full Text] [Related]
7. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
[TBL] [Abstract][Full Text] [Related]
8. The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.
Wojdasiewicz P; Poniatowski LA; Kotela A; Deszczyński J; Kotela I; Szukiewicz D
Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):395-403. PubMed ID: 24556958
[TBL] [Abstract][Full Text] [Related]
9. Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration.
Ishida Y; Kimura A; Nosaka M; Kuninaka Y; Hemmi H; Sasaki I; Kaisho T; Mukaida N; Kondo T
Sci Rep; 2017 Dec; 7(1):16833. PubMed ID: 29203799
[TBL] [Abstract][Full Text] [Related]
10. CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis.
Helmke A; Nordlohne J; Balzer MS; Dong L; Rong S; Hiss M; Shushakova N; Haller H; von Vietinghoff S
Kidney Int; 2019 Jun; 95(6):1405-1417. PubMed ID: 30948201
[TBL] [Abstract][Full Text] [Related]
11. CX3CR1/CX3CL1 Axis Mediates Platelet-Leukocyte Adhesion to Arterial Endothelium in Younger Patients with a History of Idiopathic Deep Vein Thrombosis.
Furio E; García-Fuster MJ; Redon J; Marques P; Ortega R; Sanz MJ; Piqueras L
Thromb Haemost; 2018 Mar; 118(3):562-571. PubMed ID: 29433150
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
Cormican S; Griffin MD
Front Immunol; 2021; 12():664202. PubMed ID: 34163473
[TBL] [Abstract][Full Text] [Related]
13. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
[TBL] [Abstract][Full Text] [Related]
14. Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure.
Flamant M; Mougenot N; Balse E; Le Fèvre L; Atassi F; Gautier EL; Le Goff W; Keck M; Nadaud S; Combadière C; Boissonnas A; Pavoine C
Sci Rep; 2021 Sep; 11(1):17982. PubMed ID: 34504250
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice.
Oh DJ; Dursun B; He Z; Lu L; Hoke TS; Ljubanovic D; Faubel S; Edelstein CL
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F264-71. PubMed ID: 18003857
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
[TBL] [Abstract][Full Text] [Related]
18. CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway.
Wu XM; Liu Y; Qian ZM; Luo QQ; Ke Y
Mol Neurobiol; 2016 Aug; 53(6):4010-4018. PubMed ID: 26189830
[TBL] [Abstract][Full Text] [Related]
19. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer.
Lu X
Curr Med Chem; 2022; 29(41):6228-6246. PubMed ID: 35770395
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR
Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
